Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Su TH"" wg kryterium: Autor


Tytuł :
Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan.
Autorzy :
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2020 Dec; Vol. 119 (12), pp. 1871-1875. Date of Electronic Publication: 2020 Jun 14.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/*therapeutic use
Aminoisobutyric Acids ; Carbamates ; Cyclopropanes ; Drug Combinations ; Genotype ; Heterocyclic Compounds, 4 or More Rings ; Humans ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Quinoxalines ; Ribavirin/therapeutic use ; Sofosbuvir/therapeutic use ; Sulfonamides ; Sustained Virologic Response ; Taiwan
Czasopismo naukowe
Tytuł :
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data.
Autorzy :
Hong CM; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen YW; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Liu CJ; Department of Internal Medicine and Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2020 Aug; Vol. 53 (4), pp. 569-577. Date of Electronic Publication: 2018 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
RNA, Viral/*blood
Aged ; Aged, 80 and over ; Antiviral Agents/classification ; Drug Therapy, Combination ; Female ; Genotype ; Hepacivirus/classification ; Hepacivirus/genetics ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Taiwan
Czasopismo naukowe
Tytuł :
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chou SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Aug 01; Vol. 147 (3), pp. 901-908. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Interferons/*therapeutic use
Mouth Neoplasms/*epidemiology
Ribavirin/*therapeutic use
Adult ; Aged ; Case-Control Studies ; Confounding Factors, Epidemiologic ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis.
Autorzy :
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Peng CY; School of Medicine, China Medical University, Taichung, Taiwan.; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Fang YJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Kao WY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Yang SS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taipei, Taiwan.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Lin CK; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Lai HC; School of Medicine, China Medical University, Taichung, Taiwan.; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Su WP; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Fang SU; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chang CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. .; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. .; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jun 08; Vol. 10 (1), pp. 9180. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amides/*therapeutic use
Antiviral Agents/*therapeutic use
Benzofurans/*therapeutic use
Carbamates/*therapeutic use
Cyclopropanes/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Imidazoles/*therapeutic use
Quinoxalines/*therapeutic use
Sulfonamides/*therapeutic use
Asian Continental Ancestry Group ; Drug Resistance, Viral/drug effects ; Drug Therapy, Combination/methods ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Renal Dialysis/adverse effects ; Sustained Virologic Response
Czasopismo naukowe
Tytuł :
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Hung CC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan.
Hsieh SM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Sun HY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Apr; Vol. 40 (4), pp. 758-768. Date of Electronic Publication: 2019 Nov 11.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C, Chronic*/drug therapy
Aminoisobutyric Acids ; Antiviral Agents/adverse effects ; Benzimidazoles ; Cyclopropanes ; Far East ; Genotype ; Hepacivirus/genetics ; Humans ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Quinoxalines ; Retrospective Studies ; Sulfonamides ; Taiwan
Czasopismo naukowe
Tytuł :
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chou SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Lin CH; Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2019 Dec; Vol. 34 (12), pp. 1882-1890. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Parkinsonian Disorders/*epidemiology
Adult ; Aged ; Cohort Studies ; Female ; Follow-Up Studies ; Hepatitis C, Chronic/complications ; Humans ; Interferon-alpha/therapeutic use ; Male ; Middle Aged ; Parkinsonian Disorders/complications ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins/therapeutic use ; Risk ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Hong CM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2019 Sep; Vol. 34 (9), pp. 1620-1625. Date of Electronic Publication: 2019 Feb 17.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Sofosbuvir/*therapeutic use
Aged ; Antiviral Agents/adverse effects ; Benzimidazoles/therapeutic use ; Comparative Effectiveness Research ; Female ; Fluorenes/therapeutic use ; Genotype ; Hepacivirus/genetics ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/virology ; Humans ; Imidazoles/therapeutic use ; Male ; Middle Aged ; Retrospective Studies ; Ribavirin/therapeutic use ; Sofosbuvir/adverse effects ; Sustained Virologic Response ; Taiwan ; Time Factors ; Treatment Outcome ; Uridine Monophosphate/analogs & derivatives ; Uridine Monophosphate/therapeutic use
Czasopismo naukowe
Tytuł :
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chou SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Wu SJ; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Feb; Vol. 49 (3), pp. 331-339. Date of Electronic Publication: 2018 Dec 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*administration & dosage
Hepatitis C, Chronic/*drug therapy
Lymphoma/*prevention & control
Adult ; Antiviral Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Female ; Humans ; Incidence ; Interferon-alpha/therapeutic use ; Lymphoma/epidemiology ; Male ; Middle Aged ; Polyethylene Glycols/chemistry ; Ribavirin/therapeutic use ; Taiwan
Czasopismo naukowe
Tytuł :
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
Autorzy :
Liu CJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Liu CH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2019 Feb; Vol. 34 (2), pp. 410-417. Date of Electronic Publication: 2018 Sep 20.
Typ publikacji :
Journal Article
MeSH Terms :
Coinfection*
Health Status Indicators*
Carcinoma, Hepatocellular/*epidemiology
Hepatitis B, Chronic/*diagnosis
Hepatitis C, Chronic/*diagnosis
Liver Cirrhosis/*epidemiology
Liver Neoplasms/*epidemiology
Adult ; Antiviral Agents/therapeutic use ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/virology ; Female ; Health Status ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/epidemiology ; Hepatitis B, Chronic/virology ; Hepatitis C, Chronic/drug therapy ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/virology ; Humans ; Incidence ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/virology ; Liver Neoplasms/diagnosis ; Liver Neoplasms/virology ; Male ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Sustained Virologic Response ; Taiwan/epidemiology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Hong CM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2018 Dec 21; Vol. 13 (12), pp. e0209299. Date of Electronic Publication: 2018 Dec 21 (Print Publication: 2018).
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*administration & dosage
Benzimidazoles/*administration & dosage
Fluorenes/*administration & dosage
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*virology
Ribavirin/*administration & dosage
Uridine Monophosphate/*analogs & derivatives
Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/adverse effects ; Benzimidazoles/adverse effects ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Fluorenes/adverse effects ; Genotype ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Ribavirin/adverse effects ; Safety ; Sofosbuvir ; Sustained Virologic Response ; Taiwan ; Treatment Outcome ; Uridine Monophosphate/administration & dosage ; Uridine Monophosphate/adverse effects
Czasopismo naukowe
Tytuł :
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Huang YJ; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.
Yang SS; Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan.; School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan.
Chang CH; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.
Yang SS; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Sun HY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Liu WC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Hong CM; Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Hung CC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. .; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. .; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2018 Sep 12; Vol. 8 (1), pp. 13699. Date of Electronic Publication: 2018 Sep 12.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Interferons/*therapeutic use
Sofosbuvir/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Drug Therapy, Combination/methods ; Female ; Hepatitis C, Chronic/virology ; Humans ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/virology ; Male ; Middle Aged ; Retrospective Studies ; Ribavirin/therapeutic use ; Taiwan
Czasopismo naukowe
Tytuł :
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Hong CM; Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; National Taiwan University Hospital, Jinshan Branch, New Taipei City, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2018 Mar; Vol. 33 (3), pp. 710-717.
Typ publikacji :
Journal Article
MeSH Terms :
Genotype*
Anilides/*administration & dosage
Antiviral Agents/*administration & dosage
Carbamates/*administration & dosage
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*virology
Macrocyclic Compounds/*administration & dosage
Ribavirin/*administration & dosage
Ritonavir/*administration & dosage
Sulfonamides/*administration & dosage
Uracil/*analogs & derivatives
Aged ; Aged, 80 and over ; Anilides/adverse effects ; Antiviral Agents/adverse effects ; Carbamates/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Macrocyclic Compounds/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Ribavirin/adverse effects ; Ritonavir/adverse effects ; Safety ; Sulfonamides/adverse effects ; Taiwan ; Treatment Outcome ; Uracil/administration & dosage ; Uracil/adverse effects ; Viral Load
Czasopismo naukowe
Tytuł :
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus Infection.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei.; Hepatitis Research Center, National Taiwan University Hospital, Taipei.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou.
Chen YS; Department of Surgery, National Taiwan University Hospital, Taipei.
Wang SS; Department of Surgery, National Taiwan University Hospital, Taipei.; Department of Surgery, Fu Jen Catholic University Hospital, New Taipei City, Taiwan.; Fu Jen Catholic University College of Medicine, New Taipei City, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei.; Hepatitis Research Center, National Taiwan University Hospital, Taipei.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, Taipei.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei.; Hepatitis Research Center, National Taiwan University Hospital, Taipei.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei.; Hepatitis Research Center, National Taiwan University Hospital, Taipei.; Department of Microbiology, National Taiwan University Hospital, Taipei.
Hong CM; Department of Traumatology, National Taiwan University Hospital, Taipei.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei.; Hepatitis Research Center, National Taiwan University Hospital, Taipei.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, Taipei.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei.; Hepatitis Research Center, National Taiwan University Hospital, Taipei.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, Taipei.; Genomics Research Center, Academia Sinica, Taipei.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei.; Hepatitis Research Center, National Taiwan University Hospital, Taipei.; Graduate Institute of Clinical Medicine, National Taiwan University Hospital, Taipei.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2018 Jan 06; Vol. 66 (2), pp. 289-292.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heart Transplantation*
Transplant Recipients*
Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Fluorenes/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Imidazoles/*therapeutic use
Sofosbuvir/*therapeutic use
Adult ; Antiviral Agents/adverse effects ; Benzimidazoles/adverse effects ; Drug Therapy, Combination/adverse effects ; Drug Therapy, Combination/methods ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; Fluorenes/adverse effects ; Humans ; Imidazoles/adverse effects ; Male ; Middle Aged ; Prospective Studies ; Sofosbuvir/adverse effects ; Sustained Virologic Response ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Hong CM; Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen KM; General Biologicals Corporation, Hsinchu, Taiwan.
Huang YP; General Biologicals Corporation, Hsinchu, Taiwan.
Yeh YM; General Biologicals Corporation, Hsinchu, Taiwan.
Tien HL; CurieMed Corporation, Hsinchu, Taiwan.
Liu YC; CurieMed Corporation, Hsinchu, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2018 Jan; Vol. 33 (1), pp. 291-297.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C, Chronic/*complications
Liver Cirrhosis/*diagnosis
Liver Cirrhosis/*etiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; Humans ; Matrix Metalloproteinase 9/blood ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Sensitivity and Specificity ; Urokinase-Type Plasminogen Activator/blood ; Young Adult ; beta 2-Microglobulin/blood
Czasopismo naukowe
Tytuł :
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4.
Autorzy :
Chan HLY; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Chen CJ; Academia Sinica, Taipei, Taiwan.
Omede O; Federal Ministry of Health, Abuja, Nigeria.
Al Qamish J; Gastroenterolgy Clinic, IBN Al-Nafees Hospital, Manama, Bahsrain.
Al Naamani K; Division of Gastroenterology and Hepatology, Department of Medicine, Armed Forces Hospital, Muscat, Oman.
Bane A; Gastroenterology and Hepatology, Addis Ababa University Medical School, Addis Ababa, Ethiopia.; Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia.
Tan SS; Department of Hepatology, Selayang Hospital, Selangor, Malaysia.
Simonova M; Clinic of Gastroenterology, Military Medical Academy, Sofia, Bulgaria.
Cardenas I; Communicable Diseases Division, Ministry of Health and Social Protection, Bogota, Colombia.
Derbala M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Akin O; Federal Ministry of Health, Abuja, Nigeria.
Phillips RO; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Abdelmageed MK; Hamad Medical Corporation, Doha, Qatar.
Abdulla M; Salmaniya Medical Complex, Manama, Bahrain.
Adda D; Civil Society Network on Hepatitis, Abuja, Nigeria.; Chagro-Care Trust (CCT), Jalingo, Nigeria.
Al Baqali A; Al Kindi Specialised Hospital, Manama, Bahrain.
Al Dweik N; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Ejji K; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Ghazzawi I; GI and Hepatology Department, Jordan Royal Medical Services, Amman, Jordan.
Al Kaabi S; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Sadadi M; Salmaniya Medical Complex, Manama, Bahrain.
Al Salman J; Salmaniya Medical Complex, Manama, Bahrain.
AlBadri M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al-Busafi SA; Division of Gastroenterology, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.
Al-Romaihi HE; Ministry of Public Health Qatar, Doha, Qatar.
Ampofo W; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Antonov K; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
Anyaike C; Federal Ministry of Health, Abuja, Nigeria.
Arome F; Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria.
Blach S; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Borodo MM; Aminu Kano Teaching Hospital, Kano, Nigeria.; Bayero University, Kano, Nigeria.
Brandon SM; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Bright B; LiveWell Initiative (LWI), Lagos, Nigeria.
Butt MT; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Chen DS; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; National Taiwan University, Taipei, Taiwan.
Chien RN; Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Chuang WL; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan.
Cuellar D; Department of Epidemiology and Demography, Ministry of Health and Social Protection, Bogota, Colombia.
Elbardiny AA; Ministry of Public Health Qatar, Doha, Qatar.
Estes C; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Farag E; Ministry of Public Health Qatar, Doha, Qatar.
Fung J; Department of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Gamkrelidze I; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Garcia V; Ministry of Public Health, Santo Domingo, Dominican Republic.
Genov J; University Hospital 'Queen Joanna', Sofia, Bulgaria.
Ghandour Z; BDF Hospital, Royal Medical Services, Riffa, Bahrain.
Ghuloom M; Salmaniya Medical Complex, Manama, Bahrain.
Gomez B; Pan American Health Organization, Washington, DC, USA.
Gunter J; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Habeeb J; Salmaniya Medical Complex, Manama, Bahrain.
Hajelssedig O; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Hamoudi W; Department of Gastroenterology & Hepatology, Al Bashir Hospital, Amman, Jordan.; Jordan Ministry of Health, Amman, Jordan.
Himatt SM; Ministry of Public Health Qatar, Doha, Qatar.
Hrstic I; General Hospital Pula, Pula, Croatia.
Hu CC; Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Huang CF; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan.
Hui YT; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, SAR, China.
Jahis R; Disease Control Division, Ministry of Health, Putrajaya, Malaysia.
Jelev D; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
John AK; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Kaliaskarova KS; Ministry of Healthcare and Social Development of the Republic of Kazakhstan, Astana, Kazakhstan.; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.
Kamel Y; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Miniya University, Minya, Egypt.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
Khamis J; Salmaniya Medical Complex, Manama, Bahrain.
Khattabi H; Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt.
Khoudri I; Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco.
Konysbekova A; Republican Diagnostic Center, Astana, Kazakhstan.; University Medical Center, Astana, Kazakhstan.
Kotzev I; University Hospital 'St. Marina', Varna, Bulgaria.
Lai MS; Department of Medicine, North District Hospital, Hong Kong, SAR, China.
Lao WC; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, SAR, China.
Layden J; Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, USA.
Lee MH; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Lesi O; University of Lagos, Lagos, Nigeria.; Lagos University Teaching Hospital, Lagos, Nigeria.
Li M; Division of Gastroenterology and Hepatology, Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, SAR, China.
Lo A; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Loo CK; Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, SAR, China.
Lukšić B; Clinical Department of Infectious Diseases, Split University Hospital and Split University Medical School, Split, Croatia.
Maaroufi A; Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco.
Malu AO; Benue State University Teaching Hospital, Makurdi, Nigeria.
Mateva L; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
Mitova R; University Hospital 'Queen Joanna', Sofia, Bulgaria.
Mohamed R; University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Morović M; Department of Infectious Diseases, Zadar General Hospital, Zadar, Croatia.
Murphy K; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Mustapha B; IBN SINA Hospital, Rabat, Morocco.
Nersesov A; National Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
Ngige E; Federal Ministry of Health, Abuja, Nigeria.
Njouom R; Virology Department, Centre Pasteur of Cameroon, Yaounde, Cameroon.
Njoya O; Research Laboratory on Viral Hepatitis & Health Communication, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon.
Nonković D; Department of Epidemiology, Institute of Public Health, County of Dalmatia, Split, Croatia.
Obekpa S; Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria.; Benue State University Teaching Hospital, Makurdi, Nigeria.
Oguche S; Department of Pediatrics, University of Jos, Jos, Nigeria.; Department of Medicine, University of Jos, Jos, Nigeria.; Jos University Teaching Hospital, Jos, Nigeria.
Okolo EE; Beacon Youth Initiative, Lafia, Nigeria.
Omuemu C; University of Benin, Benin City, Nigeria.
Ondoa P; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.; African Society of Laboratory Medicine, Addis Ababa, Ethiopia.
Opare-Sem O; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Owusu-Ofori S; Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Prokopenko YN; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.
Razavi H; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Razavi-Shearer D; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Razavi-Shearer K; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Redae B; Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia.; St. Paul's Hospital Millennium College, Addis Ababa, Ethiopia.
Reic T; European Liver Patients Association, Sint-Truiden, Belgium.
Rinke de Wit T; PharmAccess Foundation, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Rios C; Department of Health Promotion and Disease Prevention, Ministry of Health and Social Protection, Bogota, Colombia.
Robbins S; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Sanad SJ; BDF Hospital, Royal Medical Services, Riffa, Bahrain.
Schmelzer JD; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Sharma M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
Sultan K; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Tchernev K; 'Sofiamed' Hospital, Sofia, Bulgaria.
Tsang OTY; Department of Medicine and Geriatrics, Princess Margaret Hospital Authority, Hong Kong, SAR, China.
Tsang S; Department of Medicine, Tseung Kwan O Hospital, Hong Kong, SAR, China.
Tzeuton C; Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Ugoeze S; Federal Medical Centre, Jalingo, Nigeria.
Uzochukwu B; Institute of Public Health, University of Nigeria, Nsukka, Nigeria.
Vi R; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.; International HepatoTransplant Group, Astana, Kazakhstan.
Vince A; Medical School University of Zagreb, University Hospital of Infectious Diseases Zagreb, Zagreb, Croatia.
Wani HU; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Wong VWS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Workneh A; Non-Communicable Diseases Programme, World Health Organization, Addis Ababa, Ethiopia.; Federal Ministry of Health, Addis Ababa, Ethiopia.
Yacoub R; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Yesmembetov KI; National Scientific Center of Oncology and Transplantology, Astana, Kazakhstan.
Youbi M; Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco.
Yuen MF; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, SAR, China.
Nde H; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2017 Oct; Vol. 24 Suppl 2, pp. 25-43.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Global Health*
Models, Statistical*
Hepatitis C, Chronic/*epidemiology
Hepatitis C, Chronic/*mortality
Viremia/*epidemiology
Viremia/*mortality
Antiviral Agents/therapeutic use ; Health Policy ; Hepatitis C, Chronic/drug therapy ; Humans ; Incidence ; Prevalence ; Viremia/drug therapy
Czasopismo naukowe
Tytuł :
Strategies to manage hepatitis C virus infection disease burden-Volume 4.
Autorzy :
Chen DS; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Hamoudi W; Department of Gastroenterology & Hepatology, Al Bashir Hospital, Amman, Jordan.; Jordan Ministry of Health, Amman, Jordan.
Mustapha B; IBN SINA Hospital, Rabat, Morocco.
Layden J; Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, USA.
Nersesov A; National Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
Reic T; European Liver Patients Association, Sint-Truiden, Belgium.
Garcia V; Ministry of Public Health, Santo Domingo, Dominican Republic.
Rios C; Department of Health Promotion and Disease Prevention, Ministry of Health and Social Protection, Bogota, Colombia.
Mateva L; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
Njoya O; Research Laboratory on Viral Hepatitis & Health Communication, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon.
Al-Busafi SA; Division of Gastroenterology, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.
Abdelmageed MK; Hamad Medical Corporation, Doha, Qatar.
Abdulla M; Salmaniya Medical Complex, Manama, Bahrain.
Adda D; Civil Society Network on Hepatitis, Abuja, Nigeria.; Chagro-Care Trust (CCT), Jalingo, Nigeria.
Akin O; Federal Ministry of Health, Abuja, Nigeria.
Al Baqali A; Al Kindi Specialised Hospital, Manama, Bahrain.
Al Dweik N; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Ejji K; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Ghazzawi I; GI and Hepatology Department, Jordan Royal Medical Services, Amman, Jordan.
Al Kaabi S; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Naamani K; Division of Gastroenterology and Hepatology, Department of Medicine, Armed Forces Hospital, Muscat, Oman.
Al Qamish J; Gastroenterolgy Clinic, IBN Al-Nafees Hospital, Manama, Bahrain.
Al Sadadi M; Salmaniya Medical Complex, Manama, Bahrain.
Al Salman J; Salmaniya Medical Complex, Manama, Bahrain.
AlBadri M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al-Romaihi HE; Ministry of Public Health Qatar, Doha, Qatar.
Ampofo W; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Antonov K; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
Anyaike C; Federal Ministry of Health, Abuja, Nigeria.
Arome F; Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria.
Bane A; Gastroenterology and Hepatology, Addis Ababa University Medical School, Addis Ababa, Ethiopia.; Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia.
Blach S; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Borodo MM; Aminu Kano Teaching Hospital, Kano, Nigeria.; Bayero University, Kano, Nigeria.
Brandon SM; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Bright B; LiveWell Initiative (LWI), Lagos, Nigeria.
Butt MT; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Cardenas I; Communicable Diseases Division, Ministry of Health and Social Protection, Bogota, Colombia.
Chan HLY; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
Chen CJ; Academia Sinica, Taipei, Taiwan.
Chen PJ; National Taiwan University, Taipei, Taiwan.
Chien RN; Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Chuang WL; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan.
Cuellar D; Department of Epidemiology and Demography, Ministry of Health and Social Protection, Bogota, Colombia.
Derbala M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Elbardiny AA; Ministry of Public Health Qatar, Doha, Qatar.
Estes C; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Farag E; Ministry of Public Health Qatar, Doha, Qatar.
Fung J; Department of Medicine, The University of Hong Kong, Hong Kong, China.
Gamkrelidze I; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Genov J; University Hospital 'Queen Joanna', Sofia, Bulgaria.
Ghandour Z; BDF Hospital, Royal Medical Services, Riffa, Bahrain.
Ghuloom M; Salmaniya Medical Complex, Manama, Bahrain.
Gomez B; Pan American Health Organization, Washington, DC, USA.
Gunter J; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Habeeb J; Salmaniya Medical Complex, Manama, Bahrain.
Hajelssedig O; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Himatt SM; Ministry of Public Health Qatar, Doha, Qatar.
Hrstic I; General Hospital Pula, Pula, Croatia.
Hu CC; Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Huang CF; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan.
Hui YT; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
Jahis R; Disease Control Division, Ministry of Health, Putrajaya, Malaysia.
Jelev D; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
John AK; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Kaliaskarova KS; Ministry of Healthcare and Social Development of the Republic of Kazakhstan, Astana, Kazakhstan.; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.
Kamel Y; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Miniya University, Minya, Egypt.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Khamis J; Salmaniya Medical Complex, Manama, Bahrain.
Khattabi H; Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt.
Khoudri I; Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco.
Konysbekova A; Republican Diagnostic Center, Astana, Kazakhstan.; University Medical Center, Astana, Kazakhstan.
Kotzev I; University Hospital 'St. Marina', Varna, Bulgaria.
Lai MS; Department of Medicine, North District Hospital, Hong Kong, China.
Lao WC; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
Lee MH; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Lesi O; University of Lagos, Lagos, Nigeria.; Lagos University Teaching Hospital, Lagos, Nigeria.
Li M; Division of Gastroenterology and Hepatology, Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, China.
Lo A; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
Loo CK; Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, China.
Lukšić B; Clinical Department of Infectious Diseases, Split University Hospital and Split University Medical School, Split, Croatia.
Maaroufi A; Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco.
Malu AO; Benue State University Teaching Hospital, Makurdi, Nigeria.
Mitova R; University Hospital 'Queen Joanna', Sofia, Bulgaria.
Mohamed R; University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Morović M; Department of Infectious Diseases, Zadar General Hospital, Zadar, Croatia.
Murphy K; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Nde H; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Ngige E; Federal Ministry of Health, Abuja, Nigeria.
Njouom R; Virology Department, Centre Pasteur of Cameroon, Yaounde, Cameroon.
Nonković D; Department of Epidemiology, Institute of Public Health, Split, Croatia.
Obekpa S; Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria.; Benue State University Teaching Hospital, Makurdi, Nigeria.
Oguche S; Department of Pediatrics, University of Jos, Jos, Nigeria.; Department of Medicine, University of Jos, Jos, Nigeria.; Jos University Teaching Hospital, Jos, Nigeria.
Okolo EE; Beacon Youth Initiative, Lafia, Nigeria.
Omede O; Federal Ministry of Health, Abuja, Nigeria.
Omuemu C; University of Benin, Benin City, Nigeria.
Ondoa P; Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.; African Society of Laboratory Medicine, Addis Ababa, Ethiopia.
Opare-Sem O; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Owusu-Ofori S; Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Phillips RO; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Prokopenko YN; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.
Razavi H; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Razavi-Shearer D; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Razavi-Shearer K; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Redae B; Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia.; St. Paul's Hospital Millennium College, Addis Ababa, Ethiopia.
Rinke de Wit T; PharmAccess Foundation, Department of Global Health, University of Amsterdam, Amsterdam, The Netherlands.
Robbins S; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Sanad SJ; BDF Hospital, Royal Medical Services, Riffa, Bahrain.
Sharma M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Simonova M; Clinic of Gastroenterology, Military Medical Academy, Sofia, Bulgaria.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Sultan K; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Tan SS; Department of Hepatology, Selayang Hospital, Selangor, Malaysia.
Tchernev K; 'Sofiamed' Hospital, Sofia, Bulgaria.
Tsang OTY; Department of Medicine and Geriatrics, Princess Margaret Hospital Authority, Hong Kong, SAR China.
Tsang S; Department of Medicine, Tseung Kwan O Hospital, Hong Kong, China.
Tzeuton C; Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Ugoeze S; Federal Medical Centre, Jalingo, Nigeria.
Uzochukwu B; Institute of Public Health, University of Nigeria, Nsukka, Nigeria.
Vi R; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.; International HepatoTransplant Group, Astana, Kazakhstan.
Vince A; Medical School University of Zagreb, University Hospital of Infectious Diseases Zagreb, Zagreb, Croatia.
Wani HU; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Wong VWS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
Workneh A; Non-Communicable Diseases Programme, World Health Organization, Addis Ababa, Ethiopia.; Federal Ministry of Health, Addis Ababa, Ethiopia.
Yacoub R; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Yesmembetov KI; National Scientific Center of Oncology and Transplantation, Astana, Kazakhstan.
Youbi M; Department of Epidemiology and Disease Control, Ministry of Health, Rabat, Morocco.
Yuen MF; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Schmelzer JD; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2017 Oct; Vol. 24 Suppl 2, pp. 44-63.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Management*
Global Health*
Hepatitis C, Chronic/*epidemiology
Hepatitis C, Chronic/*mortality
Viremia/*epidemiology
Viremia/*mortality
Antiviral Agents/therapeutic use ; Health Policy ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/drug therapy ; Humans ; Incidence ; Prevalence ; Viremia/diagnosis ; Viremia/drug therapy
Czasopismo naukowe
Tytuł :
Historical epidemiology of hepatitis C virus in select countries-volume 4.
Autorzy :
Maaroufi A; National Institute of Health Administration, Rabat, Morocco.
Vince A; Medical School University of Zagreb, University Hospital of Infectious Diseases Zagreb, Zagreb, Croatia.
Himatt SM; Ministry of Public Health Qatar, Doha, Qatar.
Mohamed R; University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Fung J; Department of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Opare-Sem O; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Workneh A; Non-Communicable Diseases Programme, World Health Organization, Addis Ababa, Ethiopia.; Federal Ministry of Health, Addis Ababa, Ethiopia.
Njouom R; Virology Department, Centre Pasteur of Cameroon, Yaounde, Cameroon.
Al Ghazzawi I; GI and Hepatology Department, Jordan Royal Medical Services, Amman, Jordan.
Abdulla M; Salmaniya Medical Complex, Manama, Bahrain.
Kaliaskarova KS; Ministry of Healthcare and Social Development of the Republic of Kazakhstan, Astana, Kazakhstan.; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.
Owusu-Ofori S; Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Abdelmageed MK; Hamad Medical Corporation, Doha, Qatar.
Adda D; Civil Society Network on Hepatitis, Abuja, Nigeria.; Chagro-Care Trust (CCT), Jalingo, Nigeria.
Akin O; Federal Ministry of Health, Abuja, Nigeria.
Al Baqali A; Al Kindi Specialised Hospital, Manama, Bahrain.
Al Dweik N; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Ejji K; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Kaabi S; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al Naamani K; Division of Gastroenterology and Hepatology, Department of Medicine, Armed Forces Hospital, Muscat, Oman.
Al Qamish J; Gastroenterolgy Clinic, IBN Al-Nafees Hospital, Manama, Bahrain.
Al Sadadi M; Salmaniya Medical Complex, Manama, Bahrain.
Al Salman J; Salmaniya Medical Complex, Manama, Bahrain.
AlBadri M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Al-Busafi SA; Division of Gastroenterology, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.
Al-Romaihi HE; Ministry of Public Health Qatar, Doha, Qatar.
Ampofo W; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Antonov K; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
Anyaike C; Federal Ministry of Health, Abuja, Nigeria.
Arome F; Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria.
Bane A; Gastroenterology and Hepatology, Addis Ababa University Medical School, Addis Ababa, Ethiopia.; Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia.
Blach S; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Borodo MM; Aminu Kano Teaching Hospital, Kano, Nigeria.; Bayero University, Kano, Nigeria.
Brandon SM; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Bright B; LiveWell Initiative (LWI), Lagos, Nigeria.
Butt MT; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Cardenas I; Communicable Diseases Division, Ministry of Health and Social Protection, Bogota, Colombia.
Chan HLY; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Chen CJ; Academia Sinica, Taipei, Taiwan.
Chen DS; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; National Taiwan University, Taipei, Taiwan.
Chien RN; Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Chuang WL; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan.
Cuellar D; Department of Epidemiology and Demography, Ministry of Health and Social Protection, Bogota, Colombia.
Derbala M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Elbardiny AA; Ministry of Public Health Qatar, Doha, Qatar.
Estes C; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Farag E; Ministry of Public Health Qatar, Doha, Qatar.
Gamkrelidze I; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Garcia V; Ministry of Public Health, Santo Domingo, Dominican Republic.
Genov J; University Hospital 'Queen Joanna', Sofia, Bulgaria.
Ghandour Z; BDF Hospital, Royal Medical Services, Riffa, Bahrain.
Ghuloom M; Salmaniya Medical Complex, Manama, Bahrain.
Gomez B; Pan American Health Organization, Washington, DC, USA.
Gunter J; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Habeeb J; Salmaniya Medical Complex, Manama, Bahrain.
Hajelssedig O; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Hamoudi W; Department of Gastroenterology & Hepatology, Al Bashir Hospital, Amman, Jordan.; Jordan Ministry of Health, Amman, Jordan.
Hrstic I; General Hospital Pula, Pula, Croatia.
Hu CC; Liver Research Unit, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Huang CF; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan.
Hui YT; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, SAR, China.
Jahis R; Disease Control Division, Ministry of Health, Putrajaya, Malaysia.
Jelev D; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
John AK; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Kamel Y; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Miniya University, Minya, Egypt.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
Khamis J; Salmaniya Medical Complex, Manama, Bahrain.
Khattabi H; Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt.
Khoudri I; National Institute of Health Administration, Rabat, Morocco.
Konysbekova A; Republican Diagnostic Center, Astana, Kazakhstan.; University Medical Center, Astana, Kazakhstan.
Kotzev I; University Hospital 'St. Marina', Varna, Bulgaria.
Lai MS; Department of Medicine, North District Hospital, Hong Kong, SAR, China.
Lao WC; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, SAR, China.
Layden J; Department of Public Health Sciences, Loyola University Chicago, Chicago, IL, USA.
Lee MH; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Lesi O; University of Lagos, Lagos, Nigeria.; Lagos University Teaching Hospital, Lagos, Nigeria.
Li M; Division of Gastroenterology and Hepatology, Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, SAR, China.
Lo A; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Loo CK; Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, SAR, China.
Lukšić B; Clinical Department of Infectious Diseases, Split University Hospital and Split University Medical School, Split, Croatia.
Malu AO; Benue State University Teaching Hospital, Makurdi, Nigeria.
Mateva L; University Hospital 'St. Ivan Rilski', Sofia, Bulgaria.
Mitova R; University Hospital 'Queen Joanna', Sofia, Bulgaria.
Morović M; Department of Infectious Diseases, Zadar General Hospital, Zadar, Croatia.
Murphy K; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Mustapha B; IBN SINA Hospital, Rabat, Morocco.
Nde H; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Nersesov A; National Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
Ngige E; Federal Ministry of Health, Abuja, Nigeria.
Njoya O; Research Laboratory on Viral Hepatitis & Health Communication, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon.
Nonković D; Department of Epidemiology, Institute of Public Health, County of Dalmatia, Split, Croatia.
Obekpa S; Advocacy for the Prevention of Hepatitis in Nigeria, Jos, Nigeria.; Benue State University Teaching Hospital, Makurdi, Nigeria.
Oguche S; Department of Pediatrics, University of Jos, Jos, Nigeria.; Department of Medicine, University of Jos, Jos, Nigeria.; Jos University Teaching Hospital, Jos, Nigeria.
Okolo EE; Beacon Youth Initiative, Lafia, Nigeria.
Omede O; Federal Ministry of Health, Abuja, Nigeria.
Omuemu C; University of Benin, Benin City, Nigeria.
Ondoa P; Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.; African Society of Laboratory Medicine, Addis Ababa, Ethiopia.
Phillips RO; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Prokopenko YN; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.
Razavi H; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Razavi-Shearer D; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Redae B; Ethiopian Gastroenterological Association, Addis Ababa, Ethiopia.; St. Paul's Hospital Millennium College, Addis Ababa, Ethiopia.
Reic T; European Liver Patients Association, Sint-Truiden, Belgium.
Rinke de Wit T; PharmAccess Foundation, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Rios C; Department of Health Promotion and Disease Prevention, Ministry of Health and Social Protection, Bogota, Colombia.
Robbins S; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Sanad SJ; BDF Hospital, Royal Medical Services, Riffa, Bahrain.
Schmelzer JD; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Sharma M; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Simonova M; Clinic of Gastroenterology, Military Medical Academy, Sofia, Bulgaria.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
Sultan K; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Tan SS; Department of Hepatology, Selayang Hospital, Selangor, Malaysia.
Tchernev K; 'Sofiamed' Hospital, Sofia, Bulgaria.
Tsang OTY; Department of Medicine and Geriatrics, Princess Margaret Hospital Authority, Hong Kong, SAR, China.
Tsang S; Department of Medicine, Tseung Kwan O Hospital, Hong Kong, SAR, China.
Tzeuton C; Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Ugoeze S; Federal Medical Centre, Jalingo, Nigeria.
Uzochukwu B; Institute of Public Health, University of Nigeria, Nsukka, Nigeria.
Vi R; Republican Coordination Center for Hepatology and Gastroenterology, Astana, Kazakhstan.; International HepatoTransplant Group, Astana, Kazakhstan.
Wani HU; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Wong VWS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Yacoub R; Division of Gastroenterology, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Yesmembetov KI; National Scientific Center of Oncology and Transplantology, Astana, Kazakhstan.
Youbi M; National Institute of Health Administration, Rabat, Morocco.
Yuen MF; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, SAR, China.
Razavi-Shearer K; Center for Disease Analysis (CDA), Lafayette, CO, USA.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2017 Oct; Vol. 24 Suppl 2, pp. 8-24.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Management*
Global Health*
Hepatitis C, Chronic/*epidemiology
Antiviral Agents/therapeutic use ; Health Policy ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/mortality ; Hepatitis C, Chronic/therapy ; Humans ; Liver Transplantation ; Prevalence
Czasopismo naukowe
Tytuł :
Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up.
Autorzy :
Chen HY; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Tseng TC; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang WT; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen TC; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen PJ; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2017 Sep; Vol. 116 (9), pp. 697-704. Date of Electronic Publication: 2016 Dec 21.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B/*complications
Hepatitis C, Chronic/*complications
Adult ; Aged ; Aged, 80 and over ; DNA, Viral/blood ; Female ; Follow-Up Studies ; Hepatitis B Antibodies/blood ; Hepatitis B Core Antigens/immunology ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.
Autorzy :
Nien HC; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.; Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Hsu SJ; Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yang PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Sheu JC; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Wang JT; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chow LP; Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Kao JH; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang WS; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2017 Jan 20; Vol. 12 (1), pp. e0170028. Date of Electronic Publication: 2017 Jan 20 (Print Publication: 2017).
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Carrier Proteins/*blood
Hepatitis C, Chronic/*blood
Membrane Glycoproteins/*blood
Acute-Phase Proteins ; Adult ; Biomarkers/blood ; Case-Control Studies ; Female ; Hepatitis C, Chronic/drug therapy ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Huang CF; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Dai CY; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Huang JF; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Lin JW; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Douliou, Taiwan.
Liang CC; Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
Yang SS; Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Lin CL; Department of Gastroenterology, Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan.
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang HC; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei.
Chen PJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taiwan.
Chuang WL; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yu ML; Institute of Clinical Medicine and Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2015 Oct 15; Vol. 5, pp. 15255. Date of Electronic Publication: 2015 Oct 15.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Adult ; Aged ; Body Weight ; Dose-Response Relationship, Drug ; Female ; Genotype ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged ; RNA, Viral/analysis ; RNA, Viral/metabolism ; Recombinant Proteins/therapeutic use ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies